Cover Image
市場調查報告書

電氣生理學設備:醫療設備的開發平台評估

Electrophysiology Devices - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 350912
出版日期 內容資訊 英文 252 Pages
訂單完成後即時交付
價格
Back to Top
電氣生理學設備:醫療設備的開發平台評估 Electrophysiology Devices - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年12月01日 內容資訊: 英文 252 Pages
簡介

本報告提供全球電氣生理學設備的市場上主要的開發中產品 (醫療設備)與其臨床實驗的進展調查,再彙整產品特性比較分析 (臨床實驗的各進展階段) ,以及主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 電氣生理學設備市場概要

第3章 電氣生理學設備市場:臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各地區
  • 開發中產品:法規途徑別
  • 開發中產品:估計認證時期別
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 電氣生理學設備的企業:各臨床實驗階段的開發中產品
  • 電氣生理學設備:各臨床實驗階段的開發中產品

第5章 電氣生理學設備市場:企業·產品概要

  • AblaCor Medical Corporation
    • 開發中產品及進行中的臨床實驗概要
  • Acutus Medical, Inc.
  • Advanced Cardiac Therapeutics, Inc.
  • AFfix Medical Ltd.
  • Apama Medical, Inc.
  • AtriCure, Inc.
  • Baylor College of Medicine
  • Biosense Webster, Inc.
  • BioSig Technologies, Inc.
  • BioTex, Inc.
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardima, Inc. (Inactive)
  • CardioFocus, Inc.
  • CardioNova Ltd.
  • CathEffects LLC
  • CathRx Ltd
  • Cordis Corporation
  • CoRepair, Inc
  • CyberHeart Incorporated
  • Epicardial Technologies Inc
  • FocusStart Orthosensors
  • Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon
  • Hansen Medical, Inc.
  • Imricor Medical Systems, Inc.
  • Interventional Imaging, Inc.
  • Iowa Approach Inc.
  • Maestro Heart SA
  • Mayo Clinic
  • MC10, Inc.
  • Medicalgorithmics S.A.
  • Medispec LTD
  • Medlumics S.L.
  • Medtronic plc
  • MedWaves Incorporated
  • MicroPort Scientific
  • MRI Interventions, Inc
  • nContact, Inc.
  • North Carolina State University
  • Northwestern University
  • Philips Healthcare
  • SCR, Inc.
  • St. Jude Medical, Inc.
  • Stereotaxis, Inc.
  • Strategic Polymer Sciences, Inc
  • The Cleveland Clinic Foundation
  • University of Rochester
  • University of Texas Medical Branch at Galveston
  • Vimecon GmbH
  • Vivonics, Inc.
  • Voyage Medical

第6章 電氣生理學設備市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0285EPD

GlobalData's Medical Devices sector report, "Electrophysiology Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of Electrophysiology Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrophysiology Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Electrophysiology Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Electrophysiology Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Electrophysiology Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 8
  • 1.2 List of Figures 15

2 Introduction 16

  • 2.1 Electrophysiology Devices Overview 16

3 Products under Development 17

  • 3.1 Electrophysiology Devices - Pipeline Products by Stage of Development 17
  • 3.2 Electrophysiology Devices - Pipeline Products by Segment 18
  • 3.3 Electrophysiology Devices - Pipeline Products by Territory 19
  • 3.4 Electrophysiology Devices - Pipeline Products by Regulatory Path 20
  • 3.5 Electrophysiology Devices - Pipeline Products by Estimated Approval Date 21
  • 3.6 Electrophysiology Devices - Ongoing Clinical Trials 22

4 Electrophysiology Devices - Pipeline Products under Development by Companies 23

  • 4.1 Electrophysiology Devices Companies - Pipeline Products by Stage of Development 23
  • 4.2 Electrophysiology Devices - Pipeline Products by Stage of Development 26

5 Electrophysiology Devices Companies and Product Overview 29

  • 5.1 Advanced Cardiac Therapeutics, Inc. Company Overview 29
  • 5.2 AFfix Medical Ltd. Company Overview 31
  • 5.3 Apama Medical, Inc. Company Overview 32
  • 5.4 AtriCure Inc Company Overview 33
  • 5.5 Aust Development, LLC Company Overview 37
  • 5.6 Baylor College of Medicine Company Overview 38
  • 5.7 Ben-Gurion University of the Negev Company Overview 40
  • 5.8 Berlin Heals GmbH Company Overview 41
  • 5.9 Biosense Webster Inc Company Overview 42
  • 5.10 BioSig Technologies, Inc. Company Overview 51
  • 5.11 BioTex Inc Company Overview 52
  • 5.12 Boston Scientific Corp Company Overview 54
  • 5.13 C. R. Bard Inc Company Overview 62
  • 5.14 Cardima, Inc. (Inactive) Company Overview 63
  • 5.15 CardioNova Ltd Company Overview 65
  • 5.16 CathEffects LLC Company Overview 66
  • 5.17 CathRx Ltd Company Overview 67
  • 5.18 Cordis Corp Company Overview 72
  • 5.19 CoRepair, Inc Company Overview 74
  • 5.20 CryoTherapeutics Gmbh Company Overview 75
  • 5.21 CyberHeart Incorporated Company Overview 76
  • 5.22 EP Dynamics, Inc. Company Overview 79
  • 5.23 Epicardial Technologies Inc Company Overview 81
  • 5.24 FocusStart LLC Company Overview 82
  • 5.25 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 83
  • 5.26 Genetesis LLC Company Overview 84
  • 5.27 Hansen Medical Inc Company Overview 85
  • 5.28 Imricor Medical Systems Inc Company Overview 90
  • 5.29 Interventional Imaging, Inc. Company Overview 93
  • 5.30 Iowa Approach Inc. Company Overview 94
  • 5.31 King's College London Company Overview 97
  • 5.32 Maestro Heart SA Company Overview 98
  • 5.33 Mayo Clinic US Company Overview 99
  • 5.34 MC10, Inc. Company Overview 100
  • 5.35 Medicalgorithmics SA Company Overview 101
  • 5.36 Medispec LTD Company Overview 102
  • 5.37 Medlumics S.L. Company Overview 103
  • 5.38 Medtronic plc Company Overview 105
  • 5.39 MedWaves Incorporated Company Overview 110
  • 5.40 MicroPort Scientific Corp Company Overview 112
  • 5.41 MRI Interventions Inc Company Overview 116
  • 5.42 North Carolina State University Company Overview 118
  • 5.43 Northwestern University Company Overview 119
  • 5.44 Philips Healthcare Company Overview 121
  • 5.45 Ra Medical Systems Inc Company Overview 122
  • 5.46 SCR, Inc. Company Overview 124
  • 5.47 St. Jude Medical Inc Company Overview 125
  • 5.48 Stereotaxis Inc Company Overview 129
  • 5.49 Strategic Polymer Sciences, Inc Company Overview 131
  • 5.50 The Cleveland Clinic Foundation Company Overview 132
  • 5.51 University of Iowa Company Overview 133
  • 5.52 University of Maryland Company Overview 134
  • 5.53 University of Michigan Company Overview 135
  • 5.54 University of Rochester Company Overview 136
  • 5.55 University of Texas Medical Branch at Galveston Company Overview 137
  • 5.56 Vanderbilt University Company Overview 139
  • 5.57 Vimecon GmbH Company Overview 140
  • 5.58 Vivonics, Inc. Company Overview 142
  • 5.59 Voyage Medical Company Overview 143

6 Electrophysiology Devices- Recent Developments 144

  • 6.1 Nov 22, 2016: Experimentica Received Tekes-The Finnish Agency For Innovation Grant 144
  • 6.2 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 144
  • 6.3 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 146
  • 6.4 Nov 14, 2016: Genetesis Raises USD1.2 Million in Seed Financing 147
  • 6.5 Nov 11, 2016: AtriCure Names Sven Wehrwein to its Board of Directors 147
  • 6.6 Nov 10, 2016: Siemens Healthcare Plans IPO of Shares 147
  • 6.7 Nov 08, 2016: Corindus Vascular Robotics Reports Third Quarter 2016 Results 147
  • 6.8 Nov 07, 2016: Stereotaxis Reports 2016 Third Quarter Financial Results 148
  • 6.9 Nov 07, 2016: Uscom CEO Appointed to Govt China Initiative 150
  • 6.10 Nov 04, 2016: MRI Interventions Announces 2016 Third Quarter and Nine Month Results 151
  • 6.11 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 154
  • 6.12 Oct 28, 2016: BioSig Technologies Raises USD0.5 Million in Venture Financing 155
  • 6.13 Oct 28, 2016: Uscom Quarterly Report to 30 September 2016 155
  • 6.14 Oct 27, 2016: CardioFocus Strengthens Commercial Team with Appointments of Chief Commercial Officer and Vice President of U.S. Sales 156
  • 6.15 Oct 27, 2016: AtriCure Reports Third Quarter 2016 Financial Results 156
  • 6.16 Oct 27, 2016: Harvard Bioscience Reports Third Quarter 2016 Financial Results 157
  • 6.17 Oct 26, 2016: Acutus Medical Announces First Patient Procedure in Pivotal Atrial Fibrillation Trial (UNCOVER-AF) and Introduction of the World's First ElectroFunctional Procedure 158
  • 6.18 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 159
  • 6.19 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 161
  • 6.20 Oct 25, 2016: Bard Announces Third Quarter Results 162
  • 6.21 Oct 20, 2016: Corindus Vascular Robotics Appoints Jeff Lemaster Chief Commercial Officer 162
  • 6.22 Oct 20, 2016: Experimentica appoints new Director of In Vivo Pharmacology 163
  • 6.23 Oct 19, 2016: BioSig Technologies to Present at The MicroCap Conference in Philadelphia 163
  • 6.24 Oct 19, 2016: MicroPort EP Attends 2016 Academic Annual Meeting of the Cardiology Society of Guangdong Medical Association to Display Columbus 163
  • 6.25 Oct 19, 2016: FireMagic Cool Catheter Obtains CFDA Approval 164
  • 6.26 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 164
  • 6.27 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 166
  • 6.28 Oct 05, 2016: Ra Medical System Receive Approval in Europe for DABRA Atherectomy System 166
  • 6.29 Sep 27, 2016: CardioFocus Begins U.S. Commercialization of HeartLight System for Paroxysmal Atrial Fibrillation with First Procedure at Mount Sinai 167
  • 6.30 Sep 27, 2016: MicroPort Hosts First EMEA Regional Distributor Summit 168
  • 6.31 Sep 26, 2016: Stereotaxis Raises USD24 Million in Private Placement of Series A Preferred Stock and Warrants 168
  • 6.32 Sep 21, 2016: Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in Nation to Use THERMOCOOL SMARTTOUCH SF Catheter 169
  • 6.33 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 170
  • 6.34 Sep 13, 2016: New ESC guidelines support recent Medtronic innovations for patients with atrial fibrillation 170
  • 6.35 Sep 07, 2016: MicroPort EP Attends First Central and Western China Heart Rhythm Forum 171
  • 6.36 Sep 05, 2016: MicroPort EP Attends 5th Longcheng Cardiology Conference 172
  • 6.37 Aug 30, 2016: MPSC Announces 2016 Interim Results 172
  • 6.38 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 174
  • 6.39 Aug 17, 2016: BioSig Achieves Important Technical Milestone 176
  • 6.40 Aug 15, 2016: Biosense Webster Announces U.S. Launch of THERMOCOOL SMARTTOUCH SF Catheter 176
  • 6.41 Aug 15, 2016: MRI Interventions Announces 2016 Second Quarter and Six Month Results 177
  • 6.42 Aug 11, 2016: BioSig Technologies Achieves Important Milestone 181
  • 6.43 Aug 09, 2016: Stereotaxis Completes Niobe System Installation At Kakogawa Hospital 181
  • 6.44 Aug 09, 2016: Stereotaxis Reports 2016 Second Quarter Financial Results 182
  • 6.45 Aug 08, 2016: CyberHeart Announces Development Agreement with National Cancer Center in Japan to Treat Cardiac Arrhythmias 183
  • 6.46 Aug 05, 2016: Steerable catheter to treat cardiac arrhythmia 184
  • 6.47 Aug 04, 2016: AtriCure Reports Second Quarter 2016 Financial Results 184
  • 6.48 Aug 04, 2016: Corindus Vascular Robotics Reports Second Quarter 2016 Results 185
  • 6.49 Jul 28, 2016: Integer Holdings Reports 2016 Second Quarter Results 186
  • 6.50 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 189
  • 6.51 Jul 28, 2016: Harvard Bioscience Reports Second Quarter 2016 Financial Results 190
  • 6.52 Jul 27, 2016: Icagen Acquires SyncroPatch384 High-Throughput Electrophysiology Platform from Nanion Technologies 191
  • 6.53 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 192
  • 6.54 Jul 26, 2016: Stereotaxis Releases Second Generation V-CAS DEFLECT System In Europe 192
  • 6.55 Jul 26, 2016: A New Age for Atrial Fibrillation Ablation: BioSig's PURE EP Enhanced Electrophysiology Recording System 193
  • 6.56 Jul 26, 2016: Merit Medical Announces Appointment of New Director 194
  • 6.57 Jul 26, 2016: Bard Announces Second Quarter Results 194
  • 6.58 Jul 22, 2016: Baylor Genetics rebrand makes debut with simplified name, targeted message 195
  • 6.59 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 196
  • 6.60 Jul 19, 2016: BioSig Technologies Issues Shareholder Letter 197
  • 6.61 Jul 15, 2016: Apama Medical Raises USD9 Million in Venture Financing 201
  • 6.62 Jul 13, 2016: University Of Chicago Medicine Creating High-Tech Arrhythmia Technology Suite With Stereotaxis Niobe ES System 201
  • 6.63 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 201
  • 6.64 Jul 08, 2016: Stereotaxis Niobe ES System Installed At Texas Children's Hospital 202
  • 6.65 Jul 05, 2016: Biotectix Licensee Acutus Medical Receives CE Mark for Mapping System 202
  • 6.66 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 203
  • 6.67 Jun 27, 2016: Greatbatch Renamed Integer Holdings 203
  • 6.68 Jun 15, 2016: Siemens Healthcare Becomes Siemens Healthineers 203
  • 6.69 Jun 14, 2016: Saint Alphonsus Physician Surpasses Procedure Milestone Using Stereotaxis Niobe ES System 204
  • 6.70 Jun 10, 2016: FIRE AND ICE Data Show Fewer Repeat Ablations and Hospitalizations for AF Patients Treated with Medtronic Cryoballoon 204
  • 6.71 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 205
  • 6.72 Jun 07, 2016: Stereotaxis To Share Its Latest Technology Advancements And Clinical Evidence At Cardiostim 2016 206
  • 6.73 Jun 07, 2016: BioSig Technologies to Present at the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society 206
  • 6.74 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 207
  • 6.75 Jun 01, 2016: Paracelsus Medical University Clinical Study On Stereotaxis Technology Benefits Recognized At European Cardiac Arrhythmia Society Congress 207
  • 6.76 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 208
  • 6.77 May 27, 2016: Genetesis Raises USD0.35 Million Financing 210
  • 6.78 May 16, 2016: Otsuka Invests in ReCor Medical 210
  • 6.79 May 12, 2016: ReCor Medical Raises USD10 Million in Venture Financing 210
  • 6.80 May 09, 2016: Stereotaxis Reports 2016 First Quarter Financial Results 211
  • 6.81 May 04, 2016: Acutus Medical Receives CE Mark for the AcQMap 3D High Resolution Imaging and Mapping System 212
  • 6.82 May 04, 2016: Stereotaxis To Highlight New Clinical Results And Automation Enhancements At Heart Rhythm 2016 In San Francisco 213
  • 6.83 May 03, 2016: Boston Scientific Announces U.S. FDA Approval Of IntellaNav XP Navigation-Enabled Ablation Catheter 213
  • 6.84 May 03, 2016: Boston Scientific Announces U.S. FDA Approval of IntellaNav MiFi XP Navigation-Enabled Ablation Catheter 214
  • 6.85 May 03, 2016: CardioFocus Clinical Investigators to Present Latest HeartLight Clinical Data in Rhythm Theatre Panel Presentation at Heart Rhythm 2016 214
  • 6.86 May 02, 2016: BioSig Technologies Raises USD4.5 Million in Private Placement of Shares 216
  • 6.87 Apr 29, 2016: Stereotaxis Awarded U.S. Patent For Vmotion Spotlight Automation Feature Of Vdrive Robotic Navigation System 216
  • 6.88 Apr 28, 2016: EPD Meets Another Significant Milestone, Completing its First Human Experience 217
  • 6.89 Apr 27, 2016: BioSig Technologies to Attend Heart Rhythm Society's 37th Annual Scientific Sessions, May 4-7, 2016 in San Francisco, CA 217
  • 6.90 Apr 27, 2016: Abbott Labs to Acquire St. Jude Medical for up to USD25 Billion 218
  • 6.91 Apr 27, 2016: Boston Scientific Announces Results For First Quarter 2016 218
  • 6.92 Apr 27, 2016: Bard Announces First Quarter Results 220
  • 6.93 Apr 25, 2016: MicroPort EP Makes the First Live Broadcasting of Columbus Surgery 220
  • 6.94 Apr 20, 2016: St. Jude Medical Reports First Quarter 2016 Results 221
  • 6.95 Apr 19, 2016: Auris Surgical Robotics Acquires Hansen Medical for USD80 Million 222
  • 6.96 Apr 14, 2016: Boston Biomedical Associates Partners with CardioFocus in Premarket Approval of HeartLight System 223
  • 6.97 Apr 07, 2016: Lund University Hospital Study Validates Improved Long-Term Clinical Outcomes Using Stereotaxis Technology 223
  • 6.98 Apr 04, 2016: Medtronic Arctic Front Cryoballoon Catheters Meet Non-Inferiority Goal in Head-to-Head Trial Presented at ACC Scientific Sessions and Published in The New England Journal of Medicine 223
  • 6.99 Apr 04, 2016: CardioFocus' HeartLight System Granted FDA Approval For Treatment Of Atrial Fibrillation 224
  • 6.100 Apr 04, 2016: U.S. Hospital Surpasses 1,000 Procedures Using Stereotaxis Niobe System 226
  • 6.101 Apr 01, 2016: MicroPort and Yizheng Municipal Government Establishes "Shanghai-Yizheng Healthcare Cooperation Project" 226
  • 6.102 Mar 30, 2016: Stereotaxis Completes Patient Enrollment for Niobe System's Post-Market Surveillance in Japan 227
  • 6.103 Mar 28, 2016: Advanced Cardiac Therapeutics Successfully Completes Clinical Trial Enrollment 227
  • 6.104 Mar 28, 2016: BioSig Technologies Announces Advanced Research Program with Mayo Clinic 228
  • 6.105 Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device 228
  • 6.106 Mar 22, 2016: Acutus Medical Raises USD75 Million in Series C Financing 229
  • 6.107 Mar 14, 2016: Columbus Granted CFDA Registration Certificate 229
  • 6.108 Mar 14, 2016: MicroPort EP Attends 13th IDSS 229
  • 6.109 Mar 11, 2016: Journal of Cardiovascular Electrophysiology Publishes Special Issue Dedicated to Stereotaxis Technology 229
  • 6.110 Mar 10, 2016: Boston Scientific Receives U.S. FDA Approval For Blazer Open-Irrigated Catheter 230
  • 6.111 Mar 02, 2016: PURE EP System Pre-Clinical Data to be Presented at the 13th International Dead Sea Symposium (IDSS) 231

7 Appendix 248

  • 7.1 Methodology 248
  • 7.2 About GlobalData 251
  • 7.3 Contact Us 251
  • 7.4 Disclaimer 251

List of Tables

List of Tables

  • Table 1: Electrophysiology Devices - Pipeline Products by Stage of Development 18
  • Table 2: Electrophysiology Devices - Pipeline Products by Segment 19
  • Table 3: Electrophysiology Devices - Pipeline Products by Territory 20
  • Table 4: Electrophysiology Devices - Pipeline Products by Regulatory Path 21
  • Table 5: Electrophysiology Devices - Pipeline Products by Estimated Approval Date 22
  • Table 6: Electrophysiology Devices - Ongoing Clinical Trials 23
  • Table 7: Electrophysiology Devices Companies - Pipeline Products by Stage of Development 24
  • Table 8: Electrophysiology Devices - Pipeline Products by Stage of Development 27
  • Table 9: Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 10: ACT System - Product Status 30
  • Table 11: ACT System - Product Description 30
  • Table 12: Advanced Cardiac Therapeutics, Inc. - Ongoing Clinical Trials Overview 31
  • Table 13: ACT System - Advanced Cardiac Therapeutics First-in-man Study 31
  • Table 14: AFfix Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 15: Ventricular Tachycardia Treatment System - Product Status 32
  • Table 16: Ventricular Tachycardia Treatment System - Product Description 32
  • Table 17: Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 18: Apama Ablation Catheter - Product Status 33
  • Table 19: Apama Ablation Catheter - Product Description 33
  • Table 20: AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 21: AtriCure MIS System - Standalone - Product Status 34
  • Table 22: AtriCure MIS System - Standalone - Product Description 35
  • Table 23: Dual Epicardial And Endocardial Device - Product Status 35
  • Table 24: Dual Epicardial And Endocardial Device - Product Description 35
  • Table 25: Next Generation RF Generator - Product Status 36
  • Table 26: Next Generation RF Generator - Product Description 36
  • Table 27: AtriCure Inc - Ongoing Clinical Trials Overview 36
  • Table 28: Dual Epicardial And Endocardial Device - Combined Endoscopic Epicardial and Percutaneous AF Clinical Study 37
  • Table 29: Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 30: Endovascular Cardiac Optical Mapping Device - Product Status 38
  • Table 31: Endovascular Cardiac Optical Mapping Device - Product Description 38
  • Table 32: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 33: Electrical-Anatomical Imaging Catheter - Product Status 39
  • Table 34: Electrical-Anatomical Imaging Catheter - Product Description 40
  • Table 35: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 36: Excitation Wave Cancellation Device - Product Status 41
  • Table 37: Excitation Wave Cancellation Device - Product Description 41
  • Table 38: Berlin Heals GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 39: Berlin Heals Cardiac Microcurrent Therapy Device - Product Status 42
  • Table 40: Berlin Heals Cardiac Microcurrent Therapy Device - Product Description 42
  • Table 41: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 42: Balloon Catheter - Atrial Fibrillation - Product Status 43
  • Table 43: Balloon Catheter - Atrial Fibrillation - Product Description 44
  • Table 44: CARTO 4 - Product Status 44
  • Table 45: CARTO 4 - Product Description 44
  • Table 46: CARTO SMARTTOUCH 5D Catheter - Product Status 45
  • Table 47: CARTO SMARTTOUCH 5D Catheter - Product Description 45
  • Table 48: Computational Phase Mapping And Catheter Ablation Device - Product Status 45
  • Table 49: Computational Phase Mapping And Catheter Ablation Device - Product Description 46
  • Table 50: Navigation Guided Deflectable Sheath - Product Status 46
  • Table 51: Navigation Guided Deflectable Sheath - Product Description 46
  • Table 52: Next Generation Ablation Catheter - Product Status 47
  • Table 53: Next Generation Ablation Catheter - Product Description 47
  • Table 54: nMARQ Pulmonary Vein Isolation System - Product Status 47
  • Table 55: nMARQ Pulmonary Vein Isolation System - Product Description 48
  • Table 56: Biosense Webster Inc - Ongoing Clinical Trials Overview 49
  • Table 57: nMARQ Pulmonary Vein Isolation System - Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in the Treatment of Paroxysmal Atrial Fibrillation - A Pilot Study 50
  • Table 58: nMARQ Pulmonary Vein Isolation System - Pulmonary Veins Circular Ablation Catheter Evaluation for Atrial Fibrillation 50
  • Table 59: nMARQ Pulmonary Vein Isolation System - Remarkable nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation 50
  • Table 60: CARTO SMARTTOUCH 5D Catheter - Clinical Study for Workflow and Acute Performance Evaluation of the Thermocool Smarttouch SF-5D System (The Thermocool Smarttouch SF-5D Catheter with Temperature Sensing Capabilities and Micro Electrodes and CARTO 3 V 6.0 Technology) in Treatment of Patie 51
  • Table 61: BioSig Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 62: PURE EP System - Product Status 52
  • Table 63: PURE EP System - Product Description 52
  • Table 64: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 65: Cooled Tip Catheter - Product Status 53
  • Table 66: Cooled Tip Catheter - Product Description 53
  • Table 67: Water-cooled Catheter - Product Status 54
  • Table 68: Water-cooled Catheter - Product Description 54
  • Table 69: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 70: Cryo Balloon Catheter - Product Status 56
  • Table 71: Cryo Balloon Catheter - Product Description 56
  • Table 72: IntellaNav MiFi OI Catheter - Product Status 56
  • Table 73: IntellaNav MiFi OI Catheter - Product Description 57
  • Table 74: IntellaNav MiFi XP Catheter - Product Status 57
  • Table 75: IntellaNav MiFi XP Catheter - Product Description 57
  • Table 76: IntellaNav XP Catheter - Product Status 58
  • Table 77: IntellaNav XP Catheter - Product Description 58
  • Table 78: IntellaTip MiFi 4.5 Open-Irrigated Catheter - Product Status 58
  • Table 79: IntellaTip MiFi 4.5 Open-Irrigated Catheter - Product Description 59
  • Table 80: LabSystem PRO NextGen - Product Status 59
  • Table 81: LabSystem PRO NextGen - Product Description 59
  • Table 82: Lesion Assessment Device - Product Status 60
  • Table 83: Lesion Assessment Device - Product Description 60
  • Table 84: Next Generation Blazer Catheter - Product Status 60
  • Table 85: Next Generation Blazer Catheter - Product Description 61
  • Table 86: Next Generation IntellaTip Catheter - Product Status 61
  • Table 87: Next Generation IntellaTip Catheter - Product Description 61
  • Table 88: OI System - Product Status 62
  • Table 89: OI System - Product Description 62
  • Table 90: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 91: BARD HD MESH Mapper Catheter - Product Status 63
  • Table 92: BARD HD MESH Mapper Catheter - Product Description 63
  • Table 93: Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 94: CADENCE EPL - Product Status 64
  • Table 95: CADENCE EPL - Product Description 64
  • Table 96: EP Ablation System - Product Status 65
  • Table 97: EP Ablation System - Product Description 65
  • Table 98: CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 99: Catheter To Treat Atrial Fibrillation - Product Status 66
  • Table 100: Catheter To Treat Atrial Fibrillation - Product Description 66
  • Table 101: CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 102: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Status 67
  • Table 103: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Description 67
  • Table 104: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 105: CathRx 4mm Therapeutic Catheter - Product Status 68
  • Table 106: CathRx 4mm Therapeutic Catheter - Product Description 68
  • Table 107: CathRx 8mm Therapeutic Catheter - Product Status 69
  • Table 108: CathRx 8mm Therapeutic Catheter - Product Description 69
  • Table 109: Khelix Ablation EP Catheters - Product Status 69
  • Table 110: Khelix Ablation EP Catheters - Product Description 70
  • Table 111: Khelix Loop EP Catheters - Product Status 70
  • Table 112: Khelix Loop EP Catheters - Product Description 71
  • Table 113: Khelix Steerable EP Catheters - Product Status 71
  • Table 114: Khelix Steerable EP Catheters - Product Description 72
  • Table 115: Non-Irrigated Ablation Catheter - Product Status 72
  • Table 116: Non-Irrigated Ablation Catheter - Product Description 72
  • Table 117: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 118: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Status 73
  • Table 119: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Description 73
  • Table 120: EP Lesion Assessment Device - Product Status 74
  • Table 121: EP Lesion Assessment Device - Product Description 74
  • Table 122: CoRepair, Inc Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 123: Radiofrequency Device - Product Status 75
  • Table 124: Radiofrequency Device - Product Description 75
  • Table 125: CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 126: Cryotherapy System - Coronary Artery Disease - Product Status 76
  • Table 127: Cryotherapy System - Coronary Artery Disease - Product Description 76
  • Table 128: CyberHeart Incorporated Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 129: CyberHeart System - Product Status 77
  • Table 130: CyberHeart System - Product Description 78
  • Table 131: CyberHeart Incorporated - Ongoing Clinical Trials Overview 78
  • Table 132: CyberHeart System - CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients with Refractory Ventricular Tachycardia 79
  • Table 133: EP Dynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 134: EPD D700 System - Product Status 80
  • Table 135: EPD D700 System - Product Description 80
  • Table 136: EP Dynamics, Inc. - Ongoing Clinical Trials Overview 81
  • Table 137: EPD D700 System - Dielectric Unravelling of Radiofrequency Ablation Effectiveness: Durable-I Study 81
  • Table 138: Epicardial Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 139: Epicardial Access Device - Product Status 82
  • Table 140: Epicardial Access Device - Product Description 82
  • Table 141: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 142: Anti-coagulum Cardiac Ablation Catheter - Product Status 83
  • Table 143: Anti-coagulum Cardiac Ablation Catheter - Product Description 83
  • Table 144: Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 145: Fibrillation Catheter - Product Status 84
  • Table 146: Fibrillation Catheter - Product Description 84
  • Table 147: Genetesis LLC Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 148: CardioFlux - Product Status 85
  • Table 149: CardioFlux - Product Description 85
  • Table 150: Hansen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 151: Sensei Robotic Catheter System - LAA - Product Status 86
  • Table 152: Sensei Robotic Catheter System - LAA - Product Description 87
  • Table 153: Sensei Robotic Catheter System - Percutaneous Aortic Valve Replacement - Product Status 87
  • Table 154: Sensei Robotic Catheter System - Percutaneous Aortic Valve Replacement - Product Description 87
  • Table 155: Sensei Robotic Catheter System - PFO Closure - Product Status 88
  • Table 156: Sensei Robotic Catheter System - PFO Closure - Product Description 88
  • Table 157: Sensei X Robotic Catheter System - Atrial Fibrillation - Product Status 88
  • Table 158: Sensei X Robotic Catheter System - Atrial Fibrillation - Product Description 89
  • Table 159: Hansen Medical Inc - Ongoing Clinical Trials Overview 89

List of Figures

1.2 List of Figures

  • Figure 1: Electrophysiology Devices - Pipeline Products by Stage of Development 18
  • Figure 2: Electrophysiology Devices - Pipeline Products by Segment 19
  • Figure 3: Electrophysiology Devices - Pipeline Products by Territory 20
  • Figure 4: Electrophysiology Devices - Pipeline Products by Regulatory Path 21
  • Figure 5: Electrophysiology Devices - Pipeline Products by Estimated Approval Date 22
  • Figure 6: Electrophysiology Devices - Ongoing Clinical Trials 23
Back to Top